1 / 4

Recombinant Vaccines Market Research Report – Forecast to 2023

Recombinant Vaccines Market Research Report u2013 Forecast to 2023<br>

Rohitravan
Télécharger la présentation

Recombinant Vaccines Market Research Report – Forecast to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Recombinant Vaccines Market Recombinant Vaccines Market Growth Factors, Statistics Data, Business Growth Factors, Statistics Data, Business Opportunities, Key Players Review by Forecast to 2023 Opportunities, Key Players Review by Forecast to 2023 Recombinant Vaccines Market Highlights: The recombinant vector vaccine strategy enables triggering of T- cells or B-cells thus generating a strong cell-mediated or humoral immune response in the body against that particular immunogen. The global recombinant vaccines market is majorly driven by increasing technical advanced research, increasing number of regulatory approvals, the high prevalence of infectious diseases and growing penetration of key market players. The recombinant vaccines market is expected to exhibit a CAGR of 6.8% during the forecast period. Vaccines that are produced using recombinant DNA technology or genetic engineering are called recombinant vaccines. Some of the key players in the Recombinant Vaccines Market are • • • • • • • • • Abiomed Emergent Bio Solutions, Inc. GlaxoSmithKline Johnson & Johnson Sanofi Pasteur SA Serum Institute of India Pvt. Ltd Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Pfizer, Inc. Industry Segmentation The global recombinant vaccines market is segmented on the basis of product type, diseases, and end-user. According to the product, the market is segmented into subunit recombinant vaccines, attenuated recombinant vaccines, and vector recombinant vaccines, Considering the disease type, the market is segmented into pneumococcal disease, cancer, hepatitis B, influenza, DPT, and others. Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/6130 On account of end-user, the market is segmented into hospitals & clinics, pediatrics, adults, veterinary, and others. Veterinary is further segmented to poultry and livestock. Based on the region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe. Table Of Content Market Research Future | Pune, India

  2. 1. Report Prologue 2. Market Introduction 3. Research Methodology 4. Market Dynamics 5. Market Factor Analysis 6. Global Recombinant Vaccines Market, By Route Of Administration 6.1 Introduction 6.2 Intramuscular And Subcutaneous Administration • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 6.3 Oral Administration • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 6.4 Other Routes Of Administration • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 7. Global Recombinant Vaccines Market, By Type 7.1 Introduction 7.2 Subunit Recombinant Vaccines • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 7.3 Attenuated Recombinant Vaccines • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 7.4 Vector Recombinant Vaccines • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 8. Global Recombinant Vaccines Market, By Disease 8.1 Introduction 8.2 Pneumococcal Disease • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 Market Research Future | Pune, India

  3. 8.3 Cancer • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 8.4 Hepatitis B • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 8.5 Influenza • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 8.6 HPV (Human Papillomavirus) • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 8.7 DPT • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 8.8 Others • Market Estimates & Forecast, 2018–2023 • Market Estimates & Forecast, By Region/Country, 2018–2023 9. Global Recombinant Vaccines Market, By End-User 9.1 Introduction 9.2 Hospitals & Clinics To be continue… Browse Complete Premium Research Reporthttps://www.marketresearchfuture.com/reports/recombinant-vaccines-market-6130 Intended Audience • • • • • Pharmaceutical Manufacturers and Suppliers Medical Research Laboratories Research and Development (R&D) Companies Market Research and Consulting Service Providers Potential Investor Market Research Future | Pune, India

  4. Comprehensive Regional Analysis Americas is the top market leader in the recombinant vaccines market owing to increasing advances in research in the field of molecular biology and genetic engineering as well as increasing prevalence of infectious diseases and cancer. For instance, according to the stats presented by breast cancer organization about 12.4% of U.S. women are prone to develop invasive breast cancer over the course of her lifetime. Europe is the second largest market and holds a healthy share in the global recombinant vaccines market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure along with the alarming rate of cancer and infectious diseases. For instance, the European Commission stated that the R&D spending by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. Asia Pacific is expected to be the fastest growing market owing to the faster adaptation of healthcare technology, increasing patient pool due to cancer and infectious diseases, government initiatives to increase the healthcare quality, favorable insurance, and reimbursement policies. Key players have set up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia thus, boosting the growth of recombinant vaccines market. The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. The Middle East has the largest market share owing to the development of healthcare industry and rising availability of specialty care centers in the United Arab Emirates and Saudi Arabia. Avail Discount at https://www.marketresearchfuture.com/check-discount/6130 About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future | Pune, India

More Related